Edition:
United States

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

3.60USD
14 Jun 2019
Change (% chg)

$-0.10 (-2.70%)
Prev Close
$3.70
Open
$3.68
Day's High
$3.69
Day's Low
$3.52
Volume
44,845
Avg. Vol
79,770
52-wk High
$14.52
52-wk Low
$3.20

About

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. The Company has developed a platform that enables it to identify cancer targets, find and genetically engineer TCR,... (more)

Overall

Beta: 1.54
Market Cap(Mil.): $377.01
Shares Outstanding(Mil.): 104.73
Dividend: --
Yield (%): --

Financials

  ADAP.OQ Industry Sector
P/E (TTM): -- 103.12 37.45
EPS (TTM): -1.02 -- --
ROI: -46.22 7.69 12.16
ROE: -49.74 8.19 16.93

Earnings vs. Estimates